Product Information
HUMIRA(CF) PEN 40 MG/0.4 ML is a brand product labeled by AbbVie Inc., priced at $3366.4668 per EA under NDC 00074055402. Its NADAC has been published 393 times since Dec 19, 2018.
Manufacturer
AbbVie Inc.NDC
00074055402
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Biologic (BLA)
FDA Application
BLA125057On Market Since
3/9/2016
Price Statistics
The NADAC for HUMIRA(CF) PEN 40 MG/0.4 ML has been published 393 times since Dec 19, 2018, and over the history we have for it it has risen 41.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3366.4668 per EA |
|---|---|
| All-time high | $3371.4911 (Feb 14, 2024) |
| All-time low | $2371.9480 (Dec 19, 2018) |
| 52-week high | $3366.4668 |
| 52-week low | $3362.6974 |
| Median price | $3121.7510 |
| Average price | $3063.6942 |
| Largest weekly change | +8.0% (Jan 11, 2023) |
| Weeks tracked | 393 |
| Tracking since | Dec 19, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HUMIRA(CF) PEN 40 MG/0.4 ML?
The current National Average Drug Acquisition Cost (NADAC) for HUMIRA(CF) PEN 40 MG/0.4 ML, manufactured by AbbVie Inc., is $3366.4668 per EA (NDC 00074055402), effective Jun 24, 2026.
How has the price of HUMIRA(CF) PEN 40 MG/0.4 ML changed over time?
Over the history we have for it, the NADAC for HUMIRA(CF) PEN 40 MG/0.4 ML has risen 41.9%. It has been tracked across 393 weekly CMS publications since Dec 19, 2018.
What are the highest and lowest recorded NADAC prices for HUMIRA(CF) PEN 40 MG/0.4 ML?
Since Dec 19, 2018, the NADAC for HUMIRA(CF) PEN 40 MG/0.4 ML has ranged from a low of $2371.9480 (Dec 19, 2018) to a high of $3371.4911 (Feb 14, 2024), with a median of $3121.7510 per EA.
Are there cheaper alternatives to HUMIRA(CF) PEN 40 MG/0.4 ML?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, HUMIRA(CF) 20 MG/0.2 ML SYRINGE, is $3366.1230 per EA — about 0% below HUMIRA(CF) PEN 40 MG/0.4 ML.
Who manufactures HUMIRA(CF) PEN 40 MG/0.4 ML?
HUMIRA(CF) PEN 40 MG/0.4 ML (NDC 00074055402) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification